Re-emergence of fatal human influenza A subtype H5N1 disease

J. S.M. Peiris, W. C. Yu, C. W. Leung, C. Y. Cheung, W. F. Ng, J. M. Nicholls, T. K. Ng, K. H. Chan, S. T. Lai, W. L. Lim, K. Y. Yuen, Y. Guan

Research output: Contribution to journalArticlepeer-review

721 Citations (Scopus)

Abstract

Human disease associated with influenza A subtype H5N1 re-emerged in January, 2003, for the first time since an outbreak in Hong Kong in 1997. Patients with H5N1 disease had unusually high serum concentrations of chemokines (eg, interferon induced protein-10 [IP-10] and monokine induced by interferon γ [MIG]). Taken together with a previous report that H5N1 influenza viruses induce large amounts of proinflammatory cytokines from macrophage cultures in vitro, our findings suggest that cytokine dysfunction contributes to the pathogenesis of H5N1 disease. Development of vaccines against influenza A (H5N1) virus should be made a priority.

Original languageEnglish
Pages (from-to)617-619
Number of pages3
JournalLancet
Volume363
Issue number9409
DOIs
Publication statusPublished - Feb 21 2004
Externally publishedYes

ASJC Scopus Subject Areas

  • General Medicine

Cite this